- Category: Research
Research
Lutein shows potential as myopia management supplement
Preliminary RCT data highlights preservation of choroidal thickness in children taking lutein supplements.Research
Could RAR determine cataract risk?
Cost-effective biomarker emerges as potential tool for risk assessment and early prevention in cataract patients.Research
Dual GIP-GLP-1 RA shows superior efficacy in lowering POAG, OHT risk
Tirzepatide consistently reduced the risk of glaucomatous disease compared to GLP-1 RAs, even among high-risk patients.Research
Iron overload may increase glaucoma risk
Study proposes that systemic iron dysregulation is a modifiable risk factor for glaucomatous disease.Research
Seasonal variations play major role in CSC development
Observed increased incidence of CSC in spring and autumn provide potential insights into the disease’s pathogenesis.Research
HOYA reports 6-month data on MiYOSMART iQ spectacle lenses for pediatric myopia
Interim results find advanced lens and D.I.M.S. triple enhanced design tech to be twice as effective in controlling axial elongation and disease progression.Research
Reducing chronic inflammation minimizes AMD-linked vision loss
Mouse model demonstrates role of NLRP3 in AMD pathology and highlights potential therapeutic approaches.Research
Researchers develop clinical decision tool for GA treatment
Atrophy Advisor could help clinicians determine the optimal therapeutic approach for GA patients.Research
First real-world data shows early promise of high-dose aflibercept for wet AMD
Eight-week findings from the SPECTRUM observational study indicate a safety profile consistent with prior evaluations.Research
Study demonstrates accuracy of new platform for comparing AI-based DR screening systems
New testing platform allows for comparison of effectiveness and fairness in commercial AI systems.Research
Pseudoexfoliation glaucoma is most prevalent among Indigenous populations in the US
Study finds American Indian or Alaska Native patients are impacted by PXG and PG nearly threefold more than the general U.S. population.Research
Cannabis implicated in ocular inflammatory disease development
Cannabis use associated with higher risk of developing uveitis and other posterior segment diseases.Research
Conflicting evidence surrounds astigmatism's role in myopia
Study highlights need for further investigation into the impact of astigmatism on myopia onset and progression.Research
New QLOSI safety data supports drop as pupil selective for presbyopia
Head-to-head trial finds pilocarpine 0.4% resulted in no significant changes in ciliary muscle or lens thickness following dosing.Research
Could high HDL levels lead to lower DR risk?
Study emphasizes importance of monitoring HDL levels in patients with diabetic retinopathy.Research
HPMC injections for hypotony show vision restoration potential
New research demonstrates effectiveness of intravitreal injections in improving vision, IOP, and axial length restoration after 12 months.Research
Beta-zone PPA may be major glaucoma disease marker for Black patients
Beta-zone PPA was linked with RNFL thinning, suggesting it may be a feature of glaucomatous change.Research
GLP-1 use may lower long-term DME, DR risk
Study highlights protective effect of GLP-1 RAs against ocular complications of diabetes and disparities for racialized patientsResearch
Study identifies key risk factors for punctate inner choroidopathy patients
Study identifies key risk factors for punctate inner choroidopathy patients.Research